Travere Therapeutics, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
2/14/2025
Shares
181,174
Value ($000)
3,156
Weight
0.1%
2023 Q3 - 2024 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).